Myelogenous Leukemia
📧 Sign up to get email alerts when something new happens for Myelogenous Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial evaluating a combination of imatinib mesylate and 17-N-allylamino-17-demethoxygeldanamycin in patients with chronic myelogenou…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]
Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [Phase 2]
A Phase 2 trial evaluating CCI-779 (temsirolimus) in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [Phase 3]
This document reports a Phase 3 trial comparing imatinib (STI571) with interferon alfa plus cytarabine in newly diagnosed chronic myeloid le…
-
CLINICAL_TRIALS withdrawal · 2012-07-09Clinical Trial Update: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [NA]
A clinical trial evaluating mechanical stimulation to prevent bone density loss in patients undergoing donor stem cell transplant has been w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies [Phase 1, Phase 2]
This document provides an update on the completed Phase 1/2 trial of SB1518 for advanced myeloid malignancies.
-
CLINICAL_TRIALS withdrawal · 2012-02-23Clinical Trial Update: Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy [Phase 1]
Phase 1 safety study of a PD-L1 inhibitor sponsored by Bristol-Myers Squibb has been withdrawn. The study targeted hematologic malignancies …
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial update for the CLAG-M regimen (cladribine, cytarabine, mitoxantrone, filgrastim) in relapsed acute lymphoblastic leuk…
-
CLINICAL_TRIALS trial_result · 2011-10-10Clinical Trial Update: Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED) [Phase 1]
A Phase 1 Growth Factor Signature (GFS) Pilot Study MK0000-098 in Philadelphia chromosome-positive chronic myelogenous leukemia and Philadel…
-
CLINICAL_TRIALS withdrawal · 2011-09-27Clinical Trial Update: A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML) [Phase 2]
Phase 2 clinical trial evaluating imatinib plus valproic acid in chronic myelogenous leukemia was withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia [Phase 1]
This clinical trial update summarizes a Phase 1 study of a combination chemotherapy regimen in patients with chronic myelogenous leukemia an…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan [Phase 1, Phase 2]
This update notes the completion of a Phase 1/2 trial of BMS-354825 (dasatinib) in Japanese patients with chronic myelogenous leukemia who a…
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Rollover Study of BMS-354825 in Patients With CML and Ph+ALL [Phase 1, Phase 2]
Rollover study of BMS-354825 (dasatinib) in patients with chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblas…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by peripheral stem cell transplantation for chronic myelogenous leukemia…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy followed by peripheral stem cell transplantation and biological therapy for chronic myeloge…
-
CLINICAL_TRIALS trial_result · 2009-08-27Clinical Trial Update: Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating allogeneic stem cell transplantation with partial T cell depletion in chronic myelogenous leukemia; the …
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 3]
This document reports a Phase 3 clinical trial evaluating haploidentical hematopoietic stem cell transplantation in patients with hematologi…